studi
approv
institut
human
ethic
committe
nation
institut
virolog
niv
india
niv
invit
variou
state
govern
local
health
author
investig
epidem
viral
diseas
includ
hepat
epidem
hepat
e
written
inform
consent
obtain
studi
subject
local
health
author
nation
institut
virolog
healthi
pregnant
women
bled
request
health
author
identif
igmantihev
posit
monitor
symptom
sever
diseas
tabl
provid
detail
studi
popul
diagnosi
hepat
e
base
presenc
antihevigm
antibodi
elisa
igmantihev
posit
includ
studi
patient
examin
within
two
week
onset
clinic
symptom
group
acutephas
convalesc
phase
patient
studi
week
postdiseas
onset
studi
group
includ
healthi
nonpregn
control
nprcontrol
b
healthi
pregnant
control
c
healthi
pregnant
control
healthi
pregnant
control
e
nonpregn
patient
npr
earli
acut
phase
npracut
f
npr
patient
convalesc
nprconv
g
pregnant
patient
earli
acut
phase
h
pregnant
patient
earli
acut
phase
pregnant
patient
subclin
j
pregnant
patient
subclin
k
pregnant
patient
subclin
studi
period
identifi
pregnant
woman
clinic
hepat
e
group
b
includ
princip
compon
correl
analys
detail
analysi
studi
popul
identifi
epidem
hepat
e
rural
area
state
maharashtra
india
repres
acut
phase
serum
sampl
epidem
subject
hevspecif
pcr
sequenc
phylogenet
analysi
sampl
belong
two
type
appar
healthi
antihev
antibodi
neg
control
group
includ
nonpregn
subject
n
pregnant
women
second
third
trimest
studi
subject
screen
igg
igmantihev
antibodi
igmantihav
antibodi
hbsag
igmantihbc
antihcv
antibodi
elisa
abbott
usa
detail
clinic
examin
done
acut
viral
hepat
avh
case
avh
patient
typic
symptom
acut
viral
hepat
sudden
onset
fever
nausea
vomit
weak
jaundic
subclin
case
defin
igm
antihev
posit
without
elev
alt
level
clinic
symptom
time
first
sampl
develop
symptom
month
followup
titr
antihev
antibodi
determin
twofold
dilut
sera
test
elisa
plasma
biochem
paramet
pregnanc
hormon
quantit
employ
dimens
rxl
max
siemen
healthcar
usa
architect
abbott
usa
platform
respect
antihev
antibodi
titr
plasma
biochem
paramet
pregnanc
relat
hormon
level
present
mean
se
analys
p
valu
deriv
two
tail
mannwhitney
test
consid
signific
statist
analys
perform
window
softwar
spss
inc
rna
isol
fresh
blood
sampl
collect
studi
subject
edta
vacutain
bd
bioscienc
usa
plasma
pbmc
separ
within
hr
collect
ficollhypaqu
gradient
method
pbmc
studi
group
immedi
store
isol
rna
later
till
use
total
rna
isol
pbmc
use
ribopur
kit
ambion
life
technolog
usa
subject
quantit
qualiti
analysi
use
nanodrop
spectrophotomet
bioanalys
agil
technolog
usa
respect
sampl
exhibit
high
qualiti
total
rna
rin
valu
select
process
four
rna
sampl
group
pool
total
rna
per
sampl
singleend
sequenc
whole
transcriptom
barcod
librari
ng
rrnadeplet
total
rna
isol
pbmc
perform
solid
sequenc
oligo
ligat
detect
analys
life
technolog
usa
briefli
mrna
enrich
total
rna
perform
rrna
deplet
method
use
ribominu
eukaryot
kit
rrnadeplet
total
rna
sampl
pool
dilut
ercc
rna
spikein
control
mix
ambion
usa
reagent
ad
assess
platform
dynam
rang
lower
limit
detect
whole
transcriptom
cdna
barcod
librari
prepar
use
ng
rrnadeplet
total
rna
solid
total
rnaseq
kit
life
technolog
usa
barcod
librari
studi
group
combin
colorbalanc
multipl
four
equimolar
concentr
everi
multiplex
sequenc
pool
preserv
color
balanc
solid
system
sequenc
run
emuls
pcr
set
multiplex
sequenc
pool
librari
templat
pm
concentr
per
guidelin
use
solid
ez
bead
system
kit
life
technolog
usa
per
manufactur
instruct
end
bead
modifi
sampl
volum
bead
adjust
approxim
million
prior
load
solid
platform
compani
ocimumbiosolut
hyderabad
india
special
analysi
data
gener
use
ng
platform
engag
complet
analysi
accord
type
comparison
specifi
us
analysi
includ
read
also
map
ercc
sequenc
use
ercc
rna
spikein
control
concentr
valu
transform
per
volum
dilut
rrna
deplet
rna
ercc
spikein
transform
concentr
valu
fpkm
valu
use
obtain
dose
respons
plot
sampl
show
correl
valu
close
cufflink
program
use
get
transcript
abund
estim
term
fpkm
valu
express
level
calcul
base
kilobas
exon
per
million
map
fragment
fpkm
assess
replic
similar
identifi
outlier
sampl
pca
correl
plot
obtain
fpkm
valu
use
r
packag
differenti
express
analysi
done
pairwis
comparison
use
cuffdiff
cufflink
cummerbund
packag
genepattern
varianc
express
level
calcul
use
neg
binomi
distribut
pvalu
adjust
benjaminihochberg
fdr
correct
genetranscript
identifi
significantli
differenti
express
fdr
correct
pvalu
compar
transcriptom
analysi
significantli
differenti
express
genetranscript
fold
chang
consid
downstream
analysi
mean
fold
chang
valu
calcul
group
use
group
comparison
gene
ontolog
pathway
analys
carri
use
databas
annot
visual
integr
discoveri
david
kegg
databas
differenti
express
gene
deg
studi
group
enrich
base
function
use
gene
ontolog
go
enrich
david
eas
score
cutoff
kegg
pathway
least
two
gene
p
valu
consid
associ
respect
group
examin
pvalu
modifi
fisher
exact
test
pvalu
eas
score
sequenc
gener
studi
upload
ncbishort
read
archiv
sra
bioproject
real
timepcr
valid
perform
use
individu
taqman
primer
probe
sybr
greenbas
assay
select
gene
taqman
assay
differenti
express
gene
deg
rrna
endogen
control
select
includ
chemokin
receptor
cytokin
pattern
recognit
receptor
proinflammatori
cytokin
cytokin
cell
adhes
molecul
involv
tcell
activ
defens
respons
pathogen
elan
camp
plaur
transcript
factor
jun
mitochondri
apoptot
induc
immunoglobulin
gene
igj
costimulatori
molecul
taqman
primerprob
synthes
life
technolog
thermofish
usa
sybr
greenbas
assay
faststart
univers
sybr
green
master
mix
rox
roch
antimicrobi
peptid
defensin
molecul
immunoglobulin
igj
gene
rrna
endogen
control
select
repres
rna
pool
revers
transcrib
use
high
capac
cdna
kit
life
technolog
usa
use
pcr
amplif
real
time
pcr
machin
assay
rel
gene
express
valu
obtain
employ
compar
ct
method
use
appli
biosystem
system
sd
softwar
cdna
healthi
npr
pr
control
consid
calibr
analyz
rel
gene
express
patient
categori
primer
use
sybr
greenbas
assay
enlist
tabl
obtain
initi
overview
gene
express
pattern
perform
princip
compon
analysi
clearli
separ
data
hev
infect
nonpregn
pregnant
patient
three
trimest
normal
nonpregn
pregnant
control
fig
addit
sampl
within
studi
group
show
high
degre
similar
document
pearson
correl
analysi
fig
evid
heatmap
fig
acut
diseas
distinctli
differ
separ
npracut
patient
cluster
divid
trimesterdepend
subclin
infect
pregnant
control
clearli
hierarch
cluster
base
hev
infect
type
pregnanc
durat
studi
analysi
restrict
immun
respons
view
higher
mortal
later
trimest
trimest
studi
pairwis
comparison
acut
convalesc
npr
patient
done
respect
healthi
nonpregn
control
comparison
identifi
deg
common
group
gene
transcript
uniqu
acut
convalesc
phase
respect
suggest
extens
biolog
activ
convalesc
fig
identifi
biolog
process
overrepres
deg
perform
gene
ontolog
go
analysi
fals
discoveri
rate
signific
first
go
term
associ
acut
phase
relat
biosynthesi
metabol
function
immun
system
immun
respons
within
first
go
term
convalesc
patient
phase
common
go
term
indic
primari
nonspecif
immun
respons
respons
viru
immun
respons
innat
immun
respons
inflammatori
respons
fig
mount
robust
innat
well
adapt
cell
b
cell
immun
respons
uniqu
convalesc
express
blood
coagul
uniqu
acut
phase
kegg
pathway
significantli
overrepres
phase
diseas
upregul
gene
correct
multipl
test
fdr
includ
ribosom
system
lupu
erythematosu
oxid
phosphoryl
higher
gene
count
convalesc
phase
fig
identif
system
lupu
erythematosu
pathway
probabl
account
overlap
complement
pathway
larg
number
histon
gene
upregul
uniqu
immun
respons
pathway
upregul
convalesc
includ
antigen
process
present
cell
adhes
molecul
cam
proteasom
spliceosom
graftversushost
diseas
allograft
reject
hematopoiet
cell
lineag
intestin
immun
network
iga
product
correl
enter
infect
hev
pregnanc
known
modul
immun
respons
accommod
fetu
pregnanc
durat
import
factor
differenti
effect
pregnanc
viru
possibl
interact
pregnant
patient
compar
npr
control
fig
healthi
pregnant
women
correspond
trimest
fig
deg
record
acutephas
patient
overlap
suggest
common
biolog
mechan
oper
hev
infect
uniqu
diseas
pregnanc
interestingli
pattern
uniqu
gene
npr
pregnanc
associ
modul
taken
consider
number
overlap
gene
reduc
common
pr
categori
larg
differ
acut
sampl
taken
npr
pr
patient
rel
npr
control
fig
go
term
associ
initi
nonspecif
immun
respons
chemotaxi
respons
wound
defens
respons
common
patient
categori
involv
innat
respons
pr
patient
evid
enrich
go
term
tolllik
receptor
signal
pathway
pattern
recognit
receptor
signal
pathway
innat
immun
responseactiv
signal
transduct
activ
posit
regul
innat
immun
respons
uniqu
patient
third
trimest
enrich
tolllik
receptor
signal
pathway
tolllik
receptor
signal
pathway
nucleotidebind
oligomer
domain
contain
signal
pathway
go
term
specif
proinflammatori
cytokin
tnf
cytokinemedi
signal
pathway
regul
chemokin
product
posit
regul
chemokin
biosynthet
process
common
pr
patient
group
inflammatori
uniqu
pr
patient
categori
enrich
go
term
associ
cell
respons
patient
uniqu
overexpress
go
term
complement
activ
classic
pathway
humor
immun
respons
humor
immun
respons
mediat
circul
immunoglobulin
activ
plasma
protein
involv
acut
inflammatori
respons
overal
acut
phase
express
immun
respons
gene
higher
broader
pr
patient
npr
patient
exhibit
exclus
express
nonspecif
immun
respons
gene
pathway
enrich
fig
ribosom
system
lupu
erythematosu
common
patient
categori
uniqu
groupspecif
pathway
includ
oxid
phosphoryl
npracut
cytokinecytokin
receptor
interact
chemokin
signal
pathway
tolllik
receptor
signal
pathway
epitheli
cell
signal
helicobact
pylori
infect
complement
coagul
cascad
helicobact
pylori
infect
relat
go
term
includ
nfkbia
jun
gene
pattern
deg
group
total
upregul
downregul
gene
fig
fig
patient
clinic
diseas
exhibit
common
go
term
fig
relat
nonspecif
innat
immun
respons
respons
stress
defens
respons
inflammatori
respons
death
immun
system
process
go
term
uniqu
npr
patient
blood
coagul
viral
genom
replic
wherea
pr
patient
exhibit
type
interferon
product
regul
interferonbeta
product
regul
product
regul
ikappab
kinasenfkappab
cascad
sever
go
term
relat
ubiquin
process
enrich
pr
patient
none
patient
group
show
enrich
adapt
immun
respons
relat
go
term
uniqu
kegg
pathway
enrich
upregul
gene
oxid
phosphoryl
pathway
npr
patient
proteasom
pr
patient
nod
like
receptor
signal
pathway
fig
next
aim
understand
differ
biolog
process
acut
subclin
hev
infect
later
trimest
fig
compar
subclin
acut
hev
infect
trimest
rel
npr
control
pr
control
identifi
common
group
uniqu
subclin
infect
uniqu
acut
diseas
gene
respect
gene
express
third
trimest
trimest
trimest
go
term
associ
earlynonspecif
inflammatori
innat
immun
respons
tolllik
receptor
signal
pathway
pattern
recognit
receptor
signal
pathway
cell
respons
common
subclin
acut
form
diseas
fig
acut
diseas
mark
uniqu
enrich
regul
tumor
necrosi
factor
product
regul
mhc
class
ii
biosynthet
process
innat
immun
responseactiv
signal
transduct
macrophag
activ
larg
number
go
term
uniqu
subclin
infect
includ
respons
vitamin
respons
regul
transform
growth
factor
beta
receptor
signal
pathway
signal
pathway
regul
blood
coagul
posit
regul
adapt
immun
respons
base
somat
recombin
immun
receptor
built
immunoglobulin
superfamili
domain
regulatori
cell
differenti
regul
immunoglobulin
mediat
immun
respons
sever
term
relat
b
cell
activ
function
consid
kegg
pathway
fig
ribosom
system
lupu
erythematosu
cytokinecytokin
receptor
interact
chemokin
signal
pathway
common
form
hev
infect
associ
nodlik
receptor
signal
pathway
intestin
immun
network
iga
product
uniqu
subclin
infect
tolllik
receptor
signal
pathway
restrict
acut
infect
trimest
trimest
broad
inflammatori
pathway
oper
infect
type
subclin
infect
exhibit
robust
adapt
immun
respons
acut
diseas
evid
sever
overrepres
go
term
fig
earli
nonspecif
immun
respons
common
infect
type
go
term
common
acut
subclin
hev
infect
includ
respons
viru
relat
complement
activ
activ
plasma
protein
involv
acut
inflammatori
respons
regul
product
regul
tnf
product
go
term
blood
coagul
coagul
neg
regul
coagul
enrich
uniqu
subclin
categori
far
adapt
respons
consid
go
term
associ
cell
activ
prolifer
common
subclin
acut
present
howev
activ
cell
respons
seen
uniqu
subclin
categori
antigen
process
present
adapt
immun
respons
base
somat
recombin
immun
receptor
built
immunoglobulin
superfamili
domain
regul
adapt
immun
respons
antigen
process
present
peptid
polysaccharid
antigen
via
mhc
class
ii
antigen
process
present
peptid
antigen
via
mhc
class
ii
antigen
process
present
exogen
peptid
antigen
via
mhc
class
ii
humor
immun
respons
relat
go
term
humor
immun
respons
common
b
cell
mediat
immun
hladra
fcerig
ciqa
clu
uniqu
subclin
infect
could
distinguish
acut
subclin
infect
trimest
uniqu
presenc
immunityrel
kegg
pathway
cytokinecytokin
receptor
interact
antigen
process
present
hematopoiet
cell
lineag
subclin
infect
complement
coagul
cascad
epitheli
cell
signal
helicobact
pylori
infect
nfkbia
jun
gene
acut
diseas
fig
trimest
acut
subclin
hev
infect
character
overrepresent
go
term
associ
earli
nonspecif
respons
subclin
categori
adapt
immun
respons
clinic
group
respect
go
term
relat
interferon
regul
interferonbeta
product
regul
type
interferon
product
uniqu
clinic
categori
respons
vitamin
regul
myeloid
cell
differenti
leukocyt
activ
seen
subclin
categori
fig
trimest
addit
go
term
associ
respons
stress
defens
seen
subclin
infect
acut
diseas
overrepres
uniqu
go
term
posit
regul
signal
transduct
steroid
metabol
process
inflammatori
respons
posit
regul
protein
kinas
cascad
regul
product
subclin
infect
uniqu
go
term
posit
regul
lymphocyt
activ
regul
lymphocyt
activ
posit
regul
leukocyt
activ
regul
lymphocyt
differenti
respons
oxid
stress
regul
leukocyt
activ
overexpress
fig
similar
trimest
acut
categori
overrepres
adapt
immun
respons
go
term
wherea
antigen
process
present
exogen
antigen
common
trimest
regul
cell
differenti
restrict
subclin
infect
far
kegg
pathway
concern
fig
proteasom
enrich
patient
group
trimest
acut
subclin
infect
respect
associ
nodlik
receptor
signal
pathway
pathway
cancer
vhl
crkl
gene
third
trimest
system
lupu
erythematosu
proteasom
enrich
acut
diseas
fc
gamma
rmediat
phagocytosi
hck
gene
adheren
junction
gene
repres
subclin
categori
fig
evid
fig
go
term
enrich
downregul
gene
relat
apoptosi
npr
patient
nonspecif
immun
respons
antigen
process
present
exogen
antigen
convalesc
phase
fig
display
overlap
among
npr
pr
patient
fig
depict
summari
major
go
term
kegg
pathway
differenti
modul
hev
infect
without
pregnanc
valid
rnaseq
data
use
taqmanbas
quantit
rtpcr
show
excel
correl
p
valu
suggest
util
rnaseq
identifi
target
examin
subsequ
studi
employ
appropri
experiment
protocol
fig
similar
express
pattern
igj
gene
assay
confirm
observ
rnaseq
data
express
ticam
gene
correl
gene
correl
sampl
test
complet
correl
seen
remain
gene
view
associ
defensin
gene
well
ig
gene
diseas
present
pregnanc
quantit
gene
use
sybr
greenbas
quantit
real
time
pcr
fig
assay
detect
npracut
categori
gene
upregul
pregnant
patient
acut
subclin
infect
fig
except
npr
patient
similar
correl
two
assay
seen
gene
fig
could
use
singl
gene
igj
ig
gene
express
valid
similar
express
profil
seen
pregnant
control
trimest
correspond
subclin
infect
fig
addit
rais
express
igj
gene
record
rnaseq
patient
compar
trimestermatch
healthi
control
confirm
taqmanrtpcr
result
reveal
reproduc
rnaseq
result
taqman
sybr
greenbas
real
time
pcr
assay
ascertain
valid
conclus
drawn
need
confirm
cellbas
specif
assay
next
would
like
address
differenti
express
immun
respons
modul
gene
differ
patient
group
unbias
profil
approach
reveal
larg
number
immun
relat
gene
tabl
modul
though
differ
differ
group
hepat
e
patient
report
higher
express
mrna
pr
npr
selfrecov
patient
earli
acut
phase
rais
mrna
transcript
gzmm
healthi
pregnant
women
suggest
increas
circul
nknkt
cell
part
pregnancyassoci
immunomodul
hev
infect
women
led
downregul
gene
level
compar
npr
patient
appear
though
selfrecov
pr
npr
patient
behav
differ
respect
cell
compar
clinic
subclin
hev
infect
upregul
seen
subclin
infect
trimest
chang
record
trimest
dendrit
cell
dc
play
crucial
role
link
innat
adapt
immun
respons
detect
cytokin
produc
infect
cell
typei
interferon
import
therefor
surpris
despit
identifi
sever
upregul
ifninduc
gene
detect
rais
express
patient
group
studi
protein
level
detect
reduc
circul
level
patient
test
hev
infect
pregnant
nonpregn
patient
lead
induct
gene
fold
rise
seen
convalesc
higher
mrna
transcript
pregnant
patient
associ
pregnanc
statu
defensin
repres
import
group
antimicrobi
peptid
human
studi
show
involv
alpha
defensin
defa
hepat
e
clinic
subclin
categori
gene
upregul
npr
suggest
protect
role
pr
npr
patient
addit
rais
gene
express
record
pr
patient
clinic
subclin
hev
infect
compar
pr
control
rais
clinic
pr
categori
fold
regul
chang
note
group
import
observ
differenti
express
transcript
seri
molecul
member
famili
small
acid
calcium
bind
protein
increas
evid
show
protein
also
act
danger
associ
molecular
pattern
endogen
ligand
rage
increas
transcript
gene
observ
npr
patient
higher
express
acut
hepat
trimest
addit
third
trimest
normal
express
suggest
similar
role
pr
patient
well
comparison
among
acut
subclin
infect
respect
pr
control
show
upregul
differ
molecul
seri
acut
diseas
subclin
infect
exhibit
either
downregul
normal
level
immunoglobulin
gene
deserv
special
focu
human
potenti
gener
heavi
chain
gene
lightchain
gene
result
variabl
region
gene
rearrang
therefor
potenti
number
heavi
lightchain
combin
high
million
combin
context
number
gene
upregul
npr
patient
none
gene
exhibit
higher
level
pr
patient
control
pr
women
gene
downregul
compar
pr
control
ig
mrna
transcript
level
elev
categori
respect
document
hev
induc
express
ig
gene
npr
pr
patient
differ
scenario
notic
subclin
infect
compar
control
pr
women
trimest
igg
gene
ig
gene
categori
upregul
thu
number
ig
gene
express
proport
diseas
sever
antivir
activ
synerg
interferon
induct
resist
rna
dna
viru
infect
product
tnf
induc
virus
virusinfect
cell
select
kill
tnf
activ
acceler
present
studi
reveal
induct
tnf
gene
associ
subclin
hev
infect
trimest
fold
fold
respect
second
trimest
increas
seen
healthi
control
acut
diseas
wherea
chang
record
trimest
studi
first
time
provid
compar
transcriptom
analysi
pbmc
obtain
hepat
e
patient
address
impact
pregnanc
next
gener
sequenc
technolog
prove
power
tool
provid
compar
mrna
transcript
level
larg
number
gene
clinic
sampl
quantiti
easili
collect
patient
howev
posttranscript
modif
import
determin
function
outcom
studi
gener
use
use
pointer
identifi
target
gene
pathway
must
valid
appropri
experi
data
present
highlight
signific
differ
among
clinic
subclin
infect
pregnant
women
need
extend
fulmin
diseas
confirm
welldefin
immunolog
assay
first
defin
characterist
transcriptom
profil
among
nonpregn
patient
earlyacut
convalesc
diseas
phase
acut
phase
character
earli
nonspecif
immun
respons
wherea
convalesc
cytokinechemokin
inflammatori
innat
b
cell
adapt
immun
respons
seen
fig
result
reveal
transcript
level
moder
immun
respons
gener
npr
patient
base
microarray
analysi
sequenti
liver
tissu
yu
et
al
conclud
gener
attenu
immun
respons
chimpanze
infect
hev
compar
hcvinfect
chimpanze
similar
observ
liver
chimp
studi
pbmc
human
present
studi
noteworthi
add
special
signific
pbmcbase
data
second
sought
identifi
featur
wholeblood
transcriptom
uniqu
diseas
pregnanc
later
trimest
known
associ
high
mortal
consid
separ
compar
nonpregn
healthi
pregnant
control
correspond
trimest
result
clearli
show
respons
trimest
distinct
categori
pool
togeth
fine
immunolog
analys
contrast
exclus
express
nonspecif
immun
respons
gene
npr
patient
pr
patient
exhibit
broader
heighten
express
gene
associ
innat
well
adapt
b
cell
respons
fact
acutephas
pr
patient
induc
transcript
sever
addit
adaptiveimmunityassoci
pathway
even
convalesc
npr
patient
pathogen
recognit
import
step
activ
inflammatori
pathway
three
type
pattern
recognit
receptor
data
show
possibl
involv
tlr
nlr
hev
infect
note
earlier
report
tempor
activ
protein
gene
level
gene
npr
patient
reduc
pr
patient
reduct
actual
reflect
pregnanc
statu
hev
infect
overexpress
tolllik
receptor
signal
pathway
signal
pathway
pattern
recognit
receptor
signal
pathway
suggest
role
pr
patient
addit
patient
third
trimest
enrich
tolllik
receptor
signal
pathway
light
find
would
like
point
express
gene
increas
acut
hepat
e
patient
signific
reduct
evid
fulmin
categori
anoth
import
studi
sehgal
et
al
document
express
downstream
signal
molecul
significantli
regul
pregnant
women
fhfe
acut
hepat
e
taken
togeth
seem
play
crucial
role
modul
diseas
sever
pregnanc
deserv
indepth
studi
relat
prognosi
well
therapi
importantli
first
time
possibl
involv
signal
pathway
acut
diseas
third
trimest
shown
associ
subclin
hev
infect
trimest
pregnanc
driven
though
member
nlr
famili
activ
specif
bacteri
peptid
similar
dengu
rsv
report
hevinduc
nlr
activ
light
increas
express
hepat
c
patient
involv
interact
dsrna
hepatocyt
infect
invitro
invivo
hcv
current
observ
pbmc
need
extend
hepatocyt
next
aim
examin
identifi
transcript
specif
subclin
hev
infect
pregnant
women
otherwis
constitut
highrisk
categori
sever
liver
diseas
could
identifi
sever
go
term
specif
subclin
infect
compar
npr
control
howev
sever
relat
pregnanc
evidenc
comparison
pregnant
control
relationship
immunoglobulin
gene
diseas
present
noteworthi
subclin
infect
correl
upregul
lesser
number
ig
gene
correspond
acut
diseas
gene
respect
humor
respons
associ
go
term
enrich
subclin
infect
trimest
differ
seen
among
patient
fulmin
hepat
e
number
antigenspecif
iggproduc
b
cell
increas
follow
polyclon
stimul
pbmc
patient
uncompl
clinic
diseas
hand
report
higher
antihev
titr
fulmin
hepat
patient
selfrecov
nonpregn
patient
ii
lower
iggantihev
titr
pregnant
women
subclin
hev
infect
clinic
diseas
taken
togeth
antibodi
seem
play
import
role
diseas
sever
role
antibodi
diseas
sever
report
sever
viral
infect
influenza
sar
dengu
measl
note
rnaseq
data
respect
defensin
ig
gene
confirm
genespecif
real
time
pcr
fig
strengthen
associ
modul
gene
hepat
e
clinic
present
singl
pregnant
woman
third
trimest
fulmin
hepat
e
show
downregul
defensin
gene
recoveri
defensin
express
increas
remain
low
observ
lower
innat
immun
respons
need
confirm
larg
seri
would
like
address
two
small
antimicrobi
peptid
innat
immun
system
seem
role
protectionpathogenesi
hepat
e
observ
upregul
seri
molecul
transcript
acut
diseas
either
downregul
normal
level
subclin
infect
suggest
possibl
associ
outcom
hev
infect
high
level
protein
human
carcinoma
cell
strongli
associ
metastat
capabl
demonstr
strong
indic
poor
prognosi
human
breast
cancer
overexpress
alpha
defensin
hepat
e
patient
irrespect
pregnanc
clinic
present
suggest
definit
role
protect
small
cation
peptid
broad
antimicrobi
activ
abil
human
neutral
virus
describ
neutral
envelop
virus
depend
disrupt
viral
lipid
envelop
steric
interfer
receptor
bind
interact
cellular
factor
postentri
block
mous
model
defici
activ
small
intestin
paneth
cell
could
protect
mice
oral
infect
pathogen
mous
adenoviru
viru
antivir
activ
potenti
neutral
antibodi
respons
add
possibl
mechan
alpha
defensinsdepend
immun
role
alpha
defensin
seri
molecul
need
confirm
function
assay
extend
fulmin
hepat
e
respons
vitamin
uniqu
associ
subclin
infect
trimest
activ
vitamin
known
act
immun
system
modul
prevent
excess
express
inflammatori
cytokin
increas
oxid
burst
potenti
macrophag
stimul
express
potent
antimicrobi
peptid
includ
defensin
present
neutrophil
monocyt
nk
cell
certain
epitheli
cell
interest
studi
huang
et
al
microarray
analysi
pbmc
asymptomat
symptomat
influenza
infect
follow
experiment
infect
viru
human
volunt
show
activ
known
class
prr
led
symptomat
infect
absenc
downregul
characterist
asymptomat
infect
though
differenti
immun
respons
symptomat
asymptomat
hev
infect
present
studi
complic
pregnanc
statu
durat
pregnanc
similar
trend
seen
compar
nonpregn
control
acut
diseas
character
activ
tlr
addit
signal
pathway
trimest
contrari
nodlik
receptor
signal
associ
subclin
infect
trimest
transcriptom
analysi
identifi
increas
express
mrna
level
cellspecif
marker
immun
cell
type
dendrit
cell
natur
killer
cell
macrophag
group
studi
howev
involv
nk
nkt
nk
cell
carri
cell
receptor
suggest
increas
express
gzmm
gene
respect
npr
patient
alon
detect
selfrecov
pr
patient
acut
phase
part
pregnancyassoci
immunomodul
previous
lab
record
higher
proport
activ
cell
npr
patient
view
interest
note
transgen
hbv
transfer
mous
model
induct
acut
hepat
mediat
nkt
cell
myocard
balbc
shown
mediat
immun
respons
rsv
lcmv
cmv
benefici
effect
seen
role
nk
cell
determin
fulmin
outcom
hev
infect
need
evalu
similarli
data
point
possibl
involv
regulatori
cell
subclin
infect
trimest
confirm
extend
sever
diseas
absenc
induct
gene
acut
phase
irrespect
pregnanc
increas
convalesc
among
npr
patient
noteworthi
accord
earlier
observ
signific
reduct
circul
level
npr
patient
reduc
pr
patient
ii
signific
releas
cultur
supernat
pbmc
acut
phase
coupl
iii
signific
increas
releas
sampl
collect
convalesc
fhf
patient
level
increas
significantli
rise
mark
recoveri
patient
unalt
level
succumb
infect
result
suggest
protect
role
cytokin
majumdar
et
al
confirm
find
concord
express
gene
protein
level
emphas
definit
role
recoveri
even
fulmin
diseas
studi
need
explor
role
util
genemolecul
modul
treatment
sever
diseas
data
document
heighten
innat
immun
respons
term
highli
upregul
express
transcript
associ
nonspecif
primari
respons
robust
inflammatori
respons
pregnant
women
selfrecov
hepat
e
studi
reveal
immun
respons
trimest
distinctli
differ
record
definit
differ
clinic
subclin
infect
trimest
diseas
present
associ
differenti
express
seri
invers
proport
overexpress
immunoglobulin
ig
gene
possibl
involv
pregnant
patient
alpha
defensin
patient
categori
suggest
role
protect
base
confirm
gene
express
profil
obtain
studi
sever
function
studi
report
earlier
acut
well
fulmin
hepat
patient
without
pregnanc
may
summar
clinic
present
hepat
e
repres
distinct
transcript
profil
respect
immun
respons
extens
inform
data
provid
first
time
form
basi
futur
studi
help
understand
pathogenesi
fulmin
hepat
e
pregnanc
